Clinical trial
Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007
NCT00595673 is registered in ClinicalTrials.gov with Point Biomedical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007
- Lead sponsor
- Point Biomedical
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- October 31, 2003
- Enrollment
- 428 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.